SEARCH

SEARCH BY CITATION

References

  • 1
    McGlynn KA,Tsao L,Hsing AW,Devesa SS,Fraumeni JF,Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 2906.
  • 2
    Storm HH,Engholm G. Relative survival of Danish cancer patients diagnosed 1981 to 1997 and followed to 2001. A status report. Ugeskr Laeger 2002; 164: 285564. (in Danish).
  • 3
    Danish National Board of Health. Cancer incidence in Denmark 2001. Copenhagen: Danish National Board of Health, 2002.
  • 4
    El-Serag HB,Davila JA,Petersen NJ,McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 81723.
  • 5
    Surveillance Epidemiology and End Results (SEER). SEER*Stat database (software version 6.3.5): incidence – SEER 9 Registries. Bethesda, Maryland: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, 2007.
  • 6
    Storm HH,Michelsen EV,Clemmensen IH,Pihl J. The Danish Cancer Registry—history, content, quality and use. Dan Med Bull 1997; 44: 5359.
  • 7
    El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S27S34.
  • 8
    Armstrong GL,Alter MJ,McQuillan GM,Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 77782.
  • 9
    Armstrong GL,Wasley A,Simard EP,McQuillan GM,Kuhnert WL,Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 70514.
  • 10
    Dienstag JL. Hepatitis C: a bitter harvest. Ann Intern Med 2006; 144: 7701.
  • 11
    McGlynn KA,Tarone RE,El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 1198203.
  • 12
    Fattovich G,Stroffolini T,Zagni I,Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127: S3550.
  • 13
    Goodgame B,Shaheen NJ,Galanko J,El-Serag HB. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol 2003; 98: 253542.
    Direct Link:
  • 14
    Davila JA,Morgan RO,Shaib Y,McGlynn KA,El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127: 137280.
  • 15
    Dominitz JA,Boyko EJ,Koepsell TD,Heagerty PJ,Maynard C,Sporleder JL,Stenhouse A,Kling MA,Hrushesky W,Zeilman C,Sontag S,Shah N et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41: 8896.
  • 16
    Westh H,Worm AM,Jensen BL,Kroon S,Kvinesdal B,Nielsen CM,Wantzin P. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Infection 1993; 21: 11517.
  • 17
    Nelsing S,Wantzin P,Skot J,Krarup E,Nielsen TL,Krarup HB,Nielsen JO. The seroprevalence of hepatitis B and C in hospitalized Danish patients. Scand J Infect Dis 1995; 27: 4458.
  • 18
    Fisker N,Mygind LH,Krarup HB,Licht D,Georgsen J,Christensen PB. Blood borne viral infections among Danish health care workers—frequent blood exposure but low prevalence of infection. Eur J Epidemiol 2004; 19: 617.
  • 19
    Christensen PB. Epidemiology of hepatitis C. Ugeskr Laeger 1998; 160: 352932. (in Danish).
  • 20
    World Health Organization. Hepatitis C—global prevalence (update). Wkly Epidemiol Rec 1999; 74: 4257.
  • 21
    Statens Serum Institut. Reporting of hepatitis B and C. Epi-News 2001; 6: 11. (in Danish).
  • 22
    Statens Serum Institut. Acute and chronic hepatitis C 2000–2001. Epi-News 2002; 43: 11. (in Danish).
  • 23
    Statens Serum Institut. Acute and chronic hepatitis C 2002–2003. Epi-News 2004; 8: 11. (in Danish).
  • 24
    Statens Serum Institut. Acute and chronic hepatitis C 2004. Epi-News 2005; 7: 11. (in Danish).
  • 25
    Statens Serum Institut. Acute and chronic hepatitis C 2005. Epi-News 2006; 7: 11. (in Danish).
  • 26
    National Institute on Alcohol Abuse and Alcoholism. Apparent per capita ethanol consumption for the United States, 1850-2004. http://www.niaaa.nih.gov/Resources/DatabaseResources/QuickFacts/AlcoholSales/consum01.htm (accessed March 5, 2007).
  • 27
    Statistics Denmark. Sales of alcohol and tobacco, subject to excises duties by type (1995–2005). http://www.statistikbanken.dk (accessed March 5, 2007).
  • 28
    Cowie CC,Rust KF,Byrd-Holt DD,Eberhardt MS,Flegal KM,Engelgau MM,Saydah SH,Williams DE,Geiss LS,Gregg EW. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999–2002. Diabetes Care 2006; 29: 12638.
  • 29
    Støvring H,Andersen M,Beck-Nielsen H,Green A,Vach W. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet 2003; 362: 5378.
  • 30
    Shaib YH,Davila JA,McGlynn K,El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 4727.
  • 31
    El-Serag HB,Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000; 95: 356673.
    Direct Link:
  • 32
    Stokkeland K,Brandt L,Ekbom A,Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002. Hepatology 2006; 43: 5005.